GPS Wealth Strategies Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

GPS Wealth Strategies Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$170	Sell	1 -90	-99%	-$13.8K	﹤0.01%	575
2025 Q3	$12K	Buy	91 +1	+1%	+$120	﹤0.01%	1044
2025 Q2	$9.55K	Sell	90 -75	-45%	-$8.15K	﹤0.01%	1047
2025 Q1	$20.5K	Sell	165 -1	-0.6%	-$130	﹤0.01%	827
2024 Q4	$20.4K	Hold	166	–	–	﹤0.01%	792
2024 Q3	$18.5K	Hold	166	–	–	﹤0.01%	813
2024 Q2	$17.7K	Buy	166 +91	+121%	+$10K	﹤0.01%	784
2024 Q1	$9.03K	Hold	75	–	–	﹤0.01%	882
2023 Q4	$9.22K	Hold	75	–	–	﹤0.01%	857
2023 Q3	$9.71K	Hold	75	–	–	﹤0.01%	840
2023 Q2	$9.3K	Hold	75	–	–	﹤0.01%	861
2023 Q1	$11K	Buy	+75	New	+$11.1K	﹤0.01%	818
2022 Q4	–	Sell	-75	Closed	-$10K	–	632
2022 Q3	$10K	Hold	75	–	–	﹤0.01%	764
2022 Q2	$12K	Hold	75	–	–	﹤0.01%	723
2022 Q1	$12K	Hold	75	–	–	﹤0.01%	688
2021 Q4	$10K	Sell	75 -1	-1%	-$131	﹤0.01%	735
2021 Q3	$10K	Hold	76	–	–	﹤0.01%	711
2021 Q2	$14K	Buy	76 +1	+1%	+$173	﹤0.01%	670
2021 Q1	$12K	Buy	+75	New	+$12.3K	﹤0.01%	639

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GPS Wealth Strategies Group's JAZZ Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 99% in Q4 2025, selling an estimated $13.8K and leaving 1 share worth $170. The position accounts for ﹤0.01% of the portfolio, ranked #575.

GPS Wealth Strategies Group first reported a position in JAZZ in Q1 2021 and has held it in 19 quarters since. The position peaked at $20.5K in Q1 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

GPS Wealth Strategies Group held 1 share of Jazz Pharmaceuticals worth $170 as of Q4 2025.
GPS Wealth Strategies Group sold 90 Jazz Pharmaceuticals shares in Q4 2025, an estimated $13.8K.
Jazz Pharmaceuticals made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #575 holding.
GPS Wealth Strategies Group first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
GPS Wealth Strategies Group's Jazz Pharmaceuticals position peaked at $20.5K in Q1 2025.
573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.